Skip to main content
Clinical Trials/ISRCTN21335883
ISRCTN21335883
Completed
N/A

A randomised controlled trial assessing the impact of a Low Calorie Diet on weight loss in obese patients with type 2 Diabetes Mellitus treated with insulin

Imperial College London (UK)0 sites90 target enrollmentOctober 23, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Imperial College London (UK)
Enrollment
90
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32049634/ results (added 03/06/2020)

Registry
who.int
Start Date
October 23, 2012
End Date
May 1, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Imperial College London (UK)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 23/07/2015:
  • 1\. Have BMI \>30 kg/m²
  • 2\. Men or women
  • 3\. Age 18\-70 years
  • 4\. Are willing and able to give informed consent for participation in the study
  • 5\. Have been on insulin treatment \< 10 years or greater than 10 years with a fasting c\-peptide of \>600
  • Previous inclusion criteria from 11/09/2014 to 23/07/2015:
  • 1\. Have BMI \>30 kg/m²
  • 2\. Men or women
  • 3\. Age 18\-70 years

Exclusion Criteria

  • Current exclusion criteria as of 23/07/2015:
  • 1\. Have type 1 diabetes
  • 2\. Any significant diabetes microvascular complication
  • 3\. Are unable to provide written informed consent
  • 4\. Have experienced a cardiovascular disease (CVD) event in the previous 6 months
  • 5\. Are at stage 4 chronic kidney disease or greater (eGFR \<30 mL/min/1\.73 m²)
  • 6\. Have a mental incapacity, unwillingness and/or inability to understand, and be able to complete the mental health questionnaires in the provided language
  • 7\. Currently pregnant, lactating, or planning pregnancy within the study period
  • 8\. Have binge eating behaviour (will be assessed by Dutch Eating Behaviour Questionnaire)
  • 9\. Patient has condition precipitating fluid overload such as heart failure (New York Heart Association grade III\-IV) and liver cirrhosis

Outcomes

Primary Outcomes

Not specified

Similar Trials